Your browser doesn't support javascript.
loading
Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
Lopez-Aguiar, Alexandra G; Zaidi, Mohammad Y; Beal, Eliza W; Dillhoff, Mary; Cannon, John G D; Poultsides, George A; Kanji, Zaheer S; Rocha, Flavio G; Marincola Smith, Paula; Idrees, Kamran; Beems, Megan; Cho, Clifford S; Fisher, Alexander V; Weber, Sharon M; Krasnick, Bradley A; Fields, Ryan C; Cardona, Kenneth; Maithel, Shishir K.
  • Lopez-Aguiar AG; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Zaidi MY; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Beal EW; Division of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Dillhoff M; Division of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Cannon JGD; Department of Surgery, Stanford University Medical Center, Stanford, CA, USA.
  • Poultsides GA; Department of Surgery, Stanford University Medical Center, Stanford, CA, USA.
  • Kanji ZS; Department of Surgery, Virginia Mason Medical Center, Seattle, WA, USA.
  • Rocha FG; Department of Surgery, Virginia Mason Medical Center, Seattle, WA, USA.
  • Marincola Smith P; Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Idrees K; Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Beems M; Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Cho CS; Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Fisher AV; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Weber SM; Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Krasnick BA; Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
  • Fields RC; Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
  • Cardona K; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  • Maithel SK; Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA. smaithe@emory.edu.
Ann Surg Oncol ; 26(8): 2517-2524, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31004295
ABSTRACT

BACKGROUND:

Preoperative factors that reliably predict lymph node (LN) metastases in pancreatic neuroendocrine tumors (PanNETs) are unclear. The number of LNs needed to accurately stage PanNETs has not been defined.

METHODS:

Patients who underwent curative-intent resection of non-functional PanNETs at eight institutions from 2000 to 2016 were analyzed. Preoperative factors associated with LN metastases were identified. A procedure-specific target for LN retrieval to accurately stage patients was determined.

RESULTS:

Of 695 patients who underwent resection, 33% of tumors were proximal (head/uncinate) and 67% were distal (neck/body/tail). Twenty-six percent of patients (n = 158) had LN-positive disease, which was associated with a worse 5-year recurrence-free survival (RFS; 60% vs. 86%; p < 0.001). The increasing number of positive LNs was not associated with worse RFS. Preoperative factors associated with positive LNs included tumor size ≥ 2 cm (odds ratio [OR] 6.6; p < 0.001), proximal location (OR 2.5; p < 0.001), moderate versus well-differentiation (OR 2.1; p = 0.006), and Ki-67 ≥ 3% (OR 3.1; p < 0.001). LN metastases were also present in tumors without these risk factors < 2 cm (9%), distal location (19%), well-differentiated (23%), and Ki-67 < 3% (16%). Median LN retrieval was 13 for pancreatoduodenectomy (PD), but only 9 for distal pancreatectomy (DP). Given that PD routinely includes a complete regional lymphadenectomy, a minimum number of LNs to accurately stage patients was not identified. However, for DP, removal of less than seven LNs failed to discriminate 5-year RFS between LN-positive and LN-negative patients (less than seven LNs 72% vs. 83%, p = 0.198; seven or more LNs 67% vs. 86%; p = 0.002).

CONCLUSIONS:

Tumor size ≥ 2 cm, proximal location, moderate differentiation, and Ki-67 ≥ 3% are preoperative factors that predict LN positivity in resected non-functional PanNETs. Given the 9-23% incidence of LN metastases in patients without such risk factors, routine regional lymphadenectomy should be considered. PD inherently includes sufficient LN retrieval, while DP should aim to remove seven or more LNs for accurate staging.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pancreatectomía / Neoplasias Pancreáticas / Tumores Neuroendocrinos / Escisión del Ganglio Linfático / Ganglios Linfáticos / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pancreatectomía / Neoplasias Pancreáticas / Tumores Neuroendocrinos / Escisión del Ganglio Linfático / Ganglios Linfáticos / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article